These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23511843)

  • 1. To treat or not to treat perinatal depression with antidepressant medication: effects on infant growth.
    Parry BL
    Am J Psychiatry; 2013 May; 170(5):453-4. PubMed ID: 23511843
    [No Abstract]   [Full Text] [Related]  

  • 2. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
    Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT
    Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing risk and benefit: to treat or not to treat major depression during pregnancy with antidepressant medication.
    Parry BL
    Am J Psychiatry; 2009 May; 166(5):512-4. PubMed ID: 19411375
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors for depression in pregnancy.
    Susser LC; Sansone SA; Hermann AD
    Am J Obstet Gynecol; 2016 Dec; 215(6):722-730. PubMed ID: 27430585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parsing risk for the use of selective serotonin reuptake inhibitors in pregnancy.
    Yonkers KA
    Am J Psychiatry; 2009 Mar; 166(3):268-70. PubMed ID: 19255046
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacologic therapy of depression during pregnancy].
    Bellantuono C; Migliarese G; Imperadore G
    Recenti Prog Med; 2006 Feb; 97(2):94-107. PubMed ID: 16671276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Serotonin Reuptake Inhibitors as First-Line Antidepressant Therapy for Perinatal Depression.
    Latendresse G; Elmore C; Deneris A
    J Midwifery Womens Health; 2017 May; 62(3):317-328. PubMed ID: 28485526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Apgar scores in neonates with prenatal antidepressant exposure.
    Nebhinani N; Soni S
    Br J Psychiatry; 2013 Jun; 202():464. PubMed ID: 23732937
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of SSRIs during pregnancy: a controlled study.
    Altamura AC; De Gaspari IF; Rovera C; Colombo EM; Mauri MC; Fedele L
    Hum Psychopharmacol; 2013 Jan; 28(1):25-8. PubMed ID: 23166037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
    Sit D; Perel JM; Wisniewski SR; Helsel JC; Luther JF; Wisner KL
    J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with selective serotonin reuptake inhibitors during pregnancy: deceleration of weight gain because of depression or drug?
    Bodnar LM; Sunder KR; Wisner KL
    Am J Psychiatry; 2006 Jun; 163(6):986-91. PubMed ID: 16741197
    [No Abstract]   [Full Text] [Related]  

  • 12. Antidepressant use and preterm birth.
    Urato AC
    Am J Psychiatry; 2009 Oct; 166(10):1189; author reply 1189-90. PubMed ID: 19797450
    [No Abstract]   [Full Text] [Related]  

  • 13. Authors' reply.
    Kessing LV; Grøn R; Andersen PK
    Br J Psychiatry; 2013 Jun; 202():465. PubMed ID: 23882706
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent pulmonary hypertension of the newborn and maternal use of SSRIs.
    Wooltorton E
    CMAJ; 2006 May; 174(11):1555-6. PubMed ID: 16670395
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.
    Nezvalová-Henriksen K; Spigset O; Brandlistuen RE; Ystrom E; Koren G; Nordeng H
    Int J Epidemiol; 2016 Dec; 45(6):2018-2029. PubMed ID: 27188860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of major depressive disorder and antidepressant medication before and during pregnancy on obstetric and neonatal outcomes: A nationwide population-based study.
    Wolgast E; Lilliecreutz C; Sydsjö G; Bladh M; Josefsson A
    Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():42-50. PubMed ID: 33359923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised.
    Gustafsson HC; Goodman SH; Feng T; Choi J; Lee S; Newport DJ; Knight B; Pingeton B; Stowe ZN; Monk C
    Dev Psychopathol; 2018 Aug; 30(3):773-785. PubMed ID: 30068426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal depression: navigating the treatment dilemmas.
    Freeman MP
    Am J Psychiatry; 2007 Aug; 164(8):1162-5. PubMed ID: 17671277
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of selective serotonin reuptake inhibitors on in vitro fertilization outcome.
    Friedman BE; Rogers JL; Shahine LK; Westphal LM; Lathi RB
    Fertil Steril; 2009 Oct; 92(4):1312-1314. PubMed ID: 19423105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.